Laporan Laba Rugi 539730 - TTM - Fredun Pharmaceuticals Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Fredun Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	966	1,155	1,338	1,655	1,877	1,957	2,245	2,250	2,423	1,498	2,747	2,874	3,004	4,281	3,482	3,649	3,903	4,060	4,563	4,973
Change (%)		19.54	15.90	23.64	13.42	4.27	14.71	0.26	7.65	-38.16	83.34	4.65	4.51	42.49	-18.67	4.82	6.95	4.02	12.39	9.00
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	716	889	1,070	1,365	1,564	1,616	1,843	1,843	1,960	1,204	2,191	2,266	2,359	3,358	2,757	2,881	3,034	3,140	3,476	3,748
Change (%)		24.27	20.32	27.59	14.57	3.33	13.99	-0.00	6.39	-38.61	82.05	3.45	4.10	42.31	-17.89	4.49	5.32	3.50	10.70	7.83
% of Revenue	74.10	77.04	79.97	82.53	83.37	82.61	82.09	81.88	80.92	80.33	79.77	78.85	78.54	78.44	79.18	78.94	77.73	77.34	76.18	75.37

Gross Operating Profit	250	265	268	289	312	340	402	408	462	295	556	608	645	923	725	769	869	920	1,087	1,225
Change (%)		6.00	1.07	7.85	8.00	9.03	18.12	1.46	13.33	-36.25	88.63	9.38	6.06	43.15	-21.48	6.05	13.07	5.84	18.16	12.72
% of Revenue	25.90	22.96	20.03	17.47	16.63	17.39	17.91	18.12	19.08	19.67	20.23	21.15	21.46	21.56	20.82	21.06	22.27	22.66	23.82	24.63

SG&A	187	190	177	182	182	187	256	109	260	210	278	118	282	338	345	356	355	384	538	583
Change (%)		1.41	-6.64	2.50	0.12	2.95	36.43	-57.28	137.64	-19.17	32.52	-57.64	139.53	19.79	2.05	3.33	-0.26	8.09	39.95	8.43
% of Revenue	19.40	16.45	13.26	10.99	9.70	9.58	11.39	4.85	10.71	14.00	10.12	4.10	9.39	7.89	9.91	9.77	9.11	9.46	11.78	11.72

R&D	-0	-1		0	-0	1		1	-0	-1
Change (%)		1,205.00			-219.11	-493.05			-124.62	406.17
% of Revenue	-0.00	-0.05		0.01	-0.01	0.04		0.04	-0.01	-0.08

OpEx	916	1,096	1,266	1,580	1,793	1,864	2,127	2,109	2,272	1,397	2,495	2,587	2,671	3,846	3,139	3,279	3,490	3,621	4,064	4,413
Change (%)		19.69	15.47	24.78	13.52	3.96	14.09	-0.87	7.73	-38.52	78.65	3.67	3.24	44.00	-18.39	4.47	6.45	3.75	12.23	8.59
% of Revenue	94.84	94.96	94.61	95.48	95.57	95.28	94.77	93.70	93.77	93.23	90.84	89.99	88.90	89.84	90.15	89.85	89.43	89.20	89.07	88.74

Operating Income	50	58	72	75	83	92	117	142	151	101	252	288	333	435	343	370	413	439	499	560
Change (%)		16.67	23.91	3.57	11.25	11.09	27.17	20.73	6.40	-32.71	147.98	14.31	15.93	30.46	-21.16	7.99	11.39	6.32	13.69	12.31
% of Revenue	5.16	5.04	5.39	4.52	4.43	4.72	5.23	6.30	6.23	6.77	9.16	10.01	11.10	10.16	9.85	10.15	10.57	10.80	10.93	11.26

Interest Expense	-36	-38	-38	-40	-39	-39	-44	-59	-65	-34	-76	-100	-108	-149	-125	-150	-162	-175	-224	-250
Change (%)		5.91	0.28	5.18	-4.58	1.59	12.16	35.17	8.94	-47.45	122.57	32.05	8.26	37.71	-15.92	19.43	8.56	7.63	28.10	11.71
% of Revenue	-3.74	-3.32	-2.87	-2.44	-2.05	-2.00	-1.96	-2.64	-2.67	-2.27	-2.75	-3.47	-3.60	-3.48	-3.60	-4.10	-4.16	-4.30	-4.90	-5.03

Net Income	17	20	20	23	33	39	63	70	83	58	108	123	130	179	156	174	177	188	197	224
Change (%)		19.25	2.16	14.50	43.92	16.11	64.34	9.72	18.89	-30.39	87.86	13.49	6.39	37.27	-12.77	11.06	1.94	6.27	5.01	13.35
% of Revenue	1.71	1.71	1.51	1.39	1.77	1.97	2.82	3.09	3.41	3.84	3.93	4.27	4.34	4.18	4.49	4.75	4.53	4.63	4.33	4.50

Source: Capital IQ

Fredun Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)